In summary, we evaluated the therapeutic effect of HGF gene-engineered skeletal myoblasts on infarcted myocardium by enhancing angiogenesis, suppressing apoptosis, and reducing myocardial fibrosis. Here, HGF is linked to Myocardial fibrosis.